1. Home
  2. EOLS vs ALLT Comparison

EOLS vs ALLT Comparison

Compare EOLS & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • ALLT
  • Stock Information
  • Founded
  • EOLS 2012
  • ALLT 1996
  • Country
  • EOLS United States
  • ALLT Israel
  • Employees
  • EOLS N/A
  • ALLT N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • ALLT Telecommunications Equipment
  • Sector
  • EOLS Health Care
  • ALLT Telecommunications
  • Exchange
  • EOLS Nasdaq
  • ALLT Nasdaq
  • Market Cap
  • EOLS 406.9M
  • ALLT 342.5M
  • IPO Year
  • EOLS 2018
  • ALLT 2006
  • Fundamental
  • Price
  • EOLS $6.50
  • ALLT $10.65
  • Analyst Decision
  • EOLS Strong Buy
  • ALLT Buy
  • Analyst Count
  • EOLS 4
  • ALLT 1
  • Target Price
  • EOLS $21.25
  • ALLT N/A
  • AVG Volume (30 Days)
  • EOLS 1.0M
  • ALLT 496.7K
  • Earning Date
  • EOLS 11-05-2025
  • ALLT 11-18-2025
  • Dividend Yield
  • EOLS N/A
  • ALLT N/A
  • EPS Growth
  • EOLS N/A
  • ALLT N/A
  • EPS
  • EOLS N/A
  • ALLT N/A
  • Revenue
  • EOLS $277,941,000.00
  • ALLT $95,342,000.00
  • Revenue This Year
  • EOLS $13.68
  • ALLT $10.64
  • Revenue Next Year
  • EOLS $27.96
  • ALLT $15.76
  • P/E Ratio
  • EOLS N/A
  • ALLT N/A
  • Revenue Growth
  • EOLS 17.15
  • ALLT 4.74
  • 52 Week Low
  • EOLS $5.71
  • ALLT $2.78
  • 52 Week High
  • EOLS $17.82
  • ALLT $11.41
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 44.82
  • ALLT 66.89
  • Support Level
  • EOLS $6.08
  • ALLT $9.55
  • Resistance Level
  • EOLS $6.36
  • ALLT $10.64
  • Average True Range (ATR)
  • EOLS 0.22
  • ALLT 0.48
  • MACD
  • EOLS 0.04
  • ALLT 0.06
  • Stochastic Oscillator
  • EOLS 71.96
  • ALLT 67.72

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About ALLT Allot Ltd.

Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.

Share on Social Networks: